Mangalam Drugs & Organics Limited (MANGALAM.BO)
INR 117.55
(-0.34%)
INR 117.55
(-0.34%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -19.74 Million | 395.23 Million | 257.09 Million | 275.49 Million | 305.47 Million | 216.92 Million |
| Net Income | -90.71 Million | 22.13 Million | 277.33 Million | 395.19 Million | 62.52 Million | -57.37 Million |
| Depreciation & Amortization | 146.5 Million | 109.88 Million | 102.49 Million | 91.75 Million | 82.17 Million | 75.12 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -125.37 Million | 133.64 Million | -155.88 Million | -199.39 Million | 56.4 Million | 112.12 Million |
| Other non-cash items | 49.84 Million | 129.56 Million | 33.15 Million | -12.05 Million | 104.36 Million | 87.04 Million |
| Investing Cash Flow | -118.27 Million | -221.72 Million | -273.25 Million | -312.85 Million | -68.72 Million | -92.55 Million |
| Investments in PPE | -118.32 Million | -279.13 Million | -276.69 Million | -314.36 Million | -69.31 Million | -93.38 Million |
| Acquisitions | 50 Thousand | 57.4 Million | 1.35 Million | 1.5 Million | 424 Thousand | 628 Thousand |
| Investment purchases | -1000.00 | - | - | - | - | - |
| Sales/Maturities of investments | - | - | 2.07 Million | - | 166 Thousand | - |
| Other Investing Activities | - | 5000.00 | 5000.00 | - | 4000.00 | 201 Thousand |
| Financing Cash Flow | 111.14 Million | -166.17 Million | 29.79 Million | 26.98 Million | -234.78 Million | -114.33 Million |
| Debt repayment | -111.14 Million | -5.27 Million | -154.64 Million | -134.42 Million | -123.11 Million | -27.9 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | -160.89 Million | 184.44 Million | 161.4 Million | -111.67 Million | -86.43 Million |
| Accounts receivables | 10.46 Million | -428 Thousand | 78.22 Million | -136.08 Million | -223.52 Million | 275.77 Million |
| Accounts payables | -199.04 Million | 425.25 Million | 111.52 Million | -139.14 Million | 241.79 Million | -52.11 Million |
| Inventory | 168.87 Million | -203.6 Million | -585.18 Million | 62.55 Million | 86.1 Million | -133.19 Million |
| Other working capital | -105.68 Million | -87.57 Million | 239.55 Million | 13.28 Million | -47.97 Million | 21.66 Million |
| Cash at beginning of period | 26.88 Million | 19.46 Million | 5.84 Million | 16.21 Million | 14.33 Million | 4.3 Million |
| Cash at end of period | 11.87 Million | 26.8 Million | 19.46 Million | 5.84 Million | 16.29 Million | 14.33 Million |
| Capital Expenditure | -118.32 Million | -279.13 Million | -276.69 Million | -314.36 Million | -69.31 Million | -93.38 Million |
| Effect of forex changes on cash | - | 1000.00 | - | -1000.00 | -1000.00 | - |
| Net cash flow / Change in cash | -15.01 Million | 7.33 Million | 13.62 Million | -10.37 Million | 1.95 Million | 10.03 Million |
| Free Cash Flow | -138.07 Million | 116.09 Million | -19.59 Million | -38.86 Million | 236.15 Million | 123.53 Million |
| Breakdown | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 FY | 2022 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 4.97 Million | -35.64 Million | -95.35 Million | -43.85 Million | 22.13 Million | 4.25 Million |
| Depreciation & Amortization | 36.28 Million | 37.39 Million | 34.18 Million | 27.49 Million | 109.88 Million | 28.83 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | - | - | 133.64 Million | - |
| Other non-cash items | 31.3 Million | -37.39 Million | -34.18 Million | -27.49 Million | 129.56 Million | -28.83 Million |
| Investing Cash Flow | - | - | - | - | -221.72 Million | - |
| Investments in PPE | - | - | - | - | -279.13 Million | - |
| Acquisitions | - | - | - | - | 57.4 Million | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | 5000.00 | - |
| Financing Cash Flow | - | - | - | - | -166.17 Million | - |
| Debt repayment | - | - | - | - | -5.27 Million | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | - | -160.89 Million | - |
| Accounts receivables | - | - | - | - | -428 Thousand | - |
| Accounts payables | - | - | - | - | 425.25 Million | - |
| Inventory | - | - | - | - | -203.6 Million | - |
| Other working capital | - | - | - | - | -87.57 Million | - |
| Cash at beginning of period | 56.62 Million | 92.26 Million | 26.88 Million | 70.73 Million | 19.46 Million | 18.99 Million |
| Cash at end of period | 129.19 Million | 56.62 Million | -95.35 Million | 26.88 Million | 26.8 Million | 4.25 Million |
| Capital Expenditure | - | - | - | - | -279.13 Million | - |
| Effect of forex changes on cash | - | - | - | - | 1000.00 | - |
| Net cash flow / Change in cash | 72.57 Million | -35.64 Million | -122.23 Million | -43.85 Million | 7.33 Million | -14.73 Million |
| Free Cash Flow | 72.57 Million | -35.64 Million | -95.35 Million | -43.85 Million | 116.09 Million | 4.25 Million |
4255
0L7G
300076
LKE
1793
004890